Thrombopoietin production in human hepatic cell cultures (HepG2) is resistant to IFN-α, IFN-β, and IFN-γ treatment

Journal of Interferon and Cytokine Research

Volumn 22, Issue 12, 2002, Pages 1185-1189

  Wolber, Eva Maria ^a   Jelkmann, Wolfgang ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA INTERFERON; RECOMBINANT BETA INTERFERON; RECOMBINANT GAMMA INTERFERON; THROMBOPOIETIN;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LIVER CELL CULTURE; MEGAKARYOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; VIRUS HEPATITIS;

EID: 0036972367     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900260475704     Document Type: Article

References (38)

1. EATON, D. L., and DE SAUVAGE, F. J. (1997). Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp. Hematol. 25, 1-7.
2. KAUSHANSKY, K. (1998). Thrombopoietin. N. Engl. J. Med. 339, 746-754.
3. SUNGARAN, R., MARKOVIC, B., and CHONG, B. H. (1997). Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 89, 101-107.
4. McCARTY, J. M., SPRUGEL, K. H., FOX, N. E., SABATH, D. E., and KAUSHANSKY, K. (1995). Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 86, 3668-3675.
5. FIELDER, P. I., GURNEY, A. L., STEFANICH, E., MARIAN, M., MOORE, M. W., CARVER-MOORE, K., and DE SAUVAGE, F. J. (1996). Regulation of thrombopoietin levels by c-mp1-mediated binding to platelets. Blood 87, 2154-2161.
6. BROUDY, V. C., LIN, N. L., SABATH, D. F., PAPAYAN-NOPOULOU, T., and KAUSHANSKY, K. (1997). Human platelets display high-affinity receptors for thrombopoietin. Blood 89, 1896-1904.
7. WOLBER, E.-M., and JELKMANN, W. (2002). Thrombopoietin: the novel hepatic hormone. News Physiol. Sci. 17, 6-10.
8. CERUTTI, A., CUSTODI, P., DURANTI, M., CAZZOLA, M., and BALDUINI, C. L. (1999). Circulating thrombopoietin in reactive conditions behaves like an acute-phase reactant. Clin. Lab. Haematol. 21, 271-275.
9. BJERRE, A., OVSTEBO, R., KIERULF, P., HALVORSEN, S., and BRANDTZAEG, P. (2000). Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts. Clin. Infect. Dis. 30, 643-647.
10. WOLBER, E.-M., and JELKMANN, W. (2000). Interleukin-6 increases thrombopoietin production in human hepatoma cells HepG2 and Hep3B. J. Interferon Cytokine Res. 20, 499-506.
11. KASER, A., BRANDACHER, G., STEURER, W., KASER, S., OFFNER, F. A., ZOLLER, HH., THEURL, I., WIDDER, W., MOLNAR, C., LUDWICZEK, O., ATKINS, M. B., MIER, J. W., and TILG, H. (2001). Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98, 2720-2725.
12. SHIOTA, G., OKUBO, M., KAWASAKI, H., and TAHARA, T. (1997). Interferon increases serum thrombopoietin in patients with chronic hepatitis C. Br. J. Haematol. 97, 340-342.
13. PECK-RADOSAVLJEVIC, M., WICHLAS, M., PIDLICH, J., SIMS, P., MENG, G., ZACHERL, J., GARG, S., DATZ, C., GANGL, A., and FERENCI, P. (1998). Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology 28, 1424-1429.
14. MARTIN, T. G., and SHUMAN, M. A. (1998). Interferon-induced thrombocytopenia: is it time for thrombopoietin. Hepatology 28, 1430-1432.
15. TANIKAWA, K. (2000). Thrombopoietin and liver diseases. J. Gastroenterol. Hepatol. 15, 579-580.
16. GOLDBERG, M. A., GLASS, G. A., CUNNINGHAM, J. M., and BUNN, H. F. (1987). The regulated expression of erythropoietin by two human hepatoma cell lines. Proc. Natl. Acad. Sci. USA 84, 7972-7976.
17. HINO, M., NISHIZAWA, Y., TAGAWA, S., YAMANE, T., MORII, H., and TATSUMI, N. (1995). Constitutive expression of the thrombopoietin gene in a human hepatoma cell line. Biochem. Biophys. Res. Commun. 217, 475-481.
18. FOLMAN, C. C., OOMS, M., KUENEN, B., DE JONG, S. M., VET, R. J. W. M., DE HAAS, M., and VON DEM BORNE, A. E. (2001). The role of thrombopoietin in postoperative thrombocytosis. Br. J. Haematol. 114, 126-133.
19. AGGARWAL, B. B., and PANDITA, R. (1994). Both type I and type II interferons downregulate human tumor necrosis factor receptors in human hepatocellular carcinoma cell line Hep G2. Role of protein kinase C. FEBS Lett. 337, 99-102.
20. YUAN, J., WEGENKA, U. M., LUTTICKEN, C., BUSCHMANN, J., DECKER, T., SCHINDLER, C., HEINRICH, P. C., and HORN, F. (1994). The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol. Cell. Biol. 14, 1657-1668.
21. GONGORA, C., DEGOLS, G., ESPERT, L., HUA, T. D., and MECHTI, N. (2000). A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II. Nucleic Acids Res. 28, 2333-2341.
22. KRÖGER, A., KÖSTER, M., SCHROEDER, K., HAUSER, H., and MUELLER, P. P. (2002). Activities of IRF-I. J. Interferon Cytokine Res. 22, 5-14.
23. WOLFF, M., and JELKMANN, W. (1993). Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures. Ann. Hematol. 66, 27-31.
24. DER, S. D., ZHOU, A., WILLIAMS, B. R., and SILVERMAN, R. H. (1998). Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95, 15623-15628.
25. WOLBER, E.-M., FANDREY, J., FRACKOWSKI, U., and JELKMANN, W. (2001). Hepatic thrombopoietin mRNA is increased in acute inflammation. Thromb. Haemost. 86, 1421-1424.
26. JILMA-STOHLAWETZ, P., FOLMAN, C. C., VON DEM BORNE, A. E., PERNERSTORFER, T., HOLLENSTEIN, U., KNECHTELSDORFER, M., EICHLER, H. G., and JILMA, B. (2001). Effects of anticoagulation on thrombopoietin release during endotoxemia. J. Lab. Clin. Med. 137, 64-69.
27. TERADA, H., BALDINI, M., EBBE, S., and MADOFF, M. A. (1966). Interaction of influenza virus with blood platelets. Blood 28, 213-228.
28. WANG, S., HE, R., PATARAPOTIKUL, J., INNIS, B. L., and ANDERSON, R. (1995). Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 213, 254-257.
29. BORDIN, G., BALLARE, M., ZIGROSSI, P., BERTONCELLI, M. C., PACCAGNINO, L., BAROLI, A., BRAMBILLA, M., MONTEVERDE, A., and INGLESE, E. (1995). A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? Clin. Exp. Rheumatol. 13(Suppl. 13), S39-S43.
30. CHELUCCI, C., FEDERICO, M., GUERRIERO, R., MATTIA, G., CASELLA, I., PELOSI, E., TESTA, U., MARIANI, G., HASSAN, H. J., and PESCHLE, C. (1998). Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 91, 1225-1234.
31. COLE, J. L., MARZEC, U. M., GUNTHEL, C. J., KARPATKIN, S., WORFORD, L., SUNDELL, I. B., LENNOX, J. L., NICHOL, J. L., and HARKER, L. A. (1998). Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood 91, 3239-3246.
32. ISHIKAWA, T., ICHIDA, T., MATSUDA, Y., SUGITANI, S., SUGIYAMA, M., KATO, T., MIYAZAKI, H., and ASAKURA, H. (2000). Expression of hepatic thrombopoietin mRNA in primary cultured hepatocytes and in rats with acute liver injury or bone marrow suppression with or without cirrhosis. J. Gastroenterol. Hepatol. 15, 647-653.
33. YAMASHITA, K., MATSUOKA, H., OCHIAI, T., MATSUSHITA, R., KUBUKI, Y., SUZUKI, M., and TSUBOUCHI, H. (2000). Hepatocyte growth factor/scatter factor enhances the thrombopoietin mRNA expression in rat hepatocytes and cirrhotic rat livers. J. Gastroenterol. Hepatol. 15, 83-90.
34. CHAN, T. M., WU, P. C., LAU, J. Y., LOK, A. S., LAI, C. L., and CHENG, I. K. (1997). Interferon treatment for hepatitis C virus infection in patients on haemodialysis. Nephrol. Dial. Transplant. 12, 1414-1419.
35. WANG, Q., MIYAKAWA, Y., FOX, N., and KAUSHANSKY, K. (2000). Interferon-α directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Blood 96, 2093-2099.
36. MARTIN, T. G., SOMBERG, K. A., MENG, Y. G., COHEN, R. L., HEID, C. A., DE SAUVAGE, F. J., and SHUMAN, M. A. (1997). Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann. Intern. Med. 127, 285-288.
37. THE INTERNATIONAL CHRONIC GRANULOMATOUS DISEASE COOPERATIVE STUDY GROUP (1991). A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N. Engl. J. Med. 324, 509-516.
38. MURAOKA, K., TSUJI, K., YOSHIDA, M., EBIHARA, Y., YAMADA, K., SUI, X., TANAKA, R., and NAKAHATA, T. (1997). Thrombopoietin-independent effect of interferon-gamma on the proliferation of human megakaryocyte progenitors. Br. J. Haematol. 98, 265-273.